Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide

Zeinab Sharifi(McGill University Health Centre), Siham Sabri(Applied Science Private University), Heather M. Duncan(McGill University Health Centre), Kolja Eppert(Ontario Institute for Cancer Research), Kevin Petrecca(McGill University Health Centre), Janusz Rak(McGill University Health Centre), Nidia Lauzon(McGill University Health Centre), Bassam Abdulkarim(University of Alberta), Julie Schmitt(McGill University Health Centre), Marie‐Christine Guiot(McGill University), Bertrand J. Jean‐Claude(McGill University), Brian Meehan(McGill University Health Centre), Paul Daniel(Brigham and Women's Hospital)
Clinical Cancer Research
September 20, 2019
Cited by 58


Related Papers